By expenditures
| Name | Title | Type |
|---|---|---|
| Craig Maynard | Vice President Of Finance And Operations/Cfo | Auditee |
| David Myron | VP of Business and Finance | Auditee |
| Kyla Greenhoe | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 393679 | 2025 | 2026-03-24 | CLIFTONLARSONALLEN LLP | $18.42M |
| 344457 | 2024 | 2025-03-03 | Cliftonlarsonallen LLP | $17.79M |
| 297294 | 2023 | 2024-03-25 | Cliftonlarsonallen LLP | $17.00M |
| 38826 | 2022 | 2023-02-08 | Cliftonlarsonallen LLP | $19.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 393679 | 2025 | 2026-03-24 | 1182280 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182279 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182278 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182277 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182276 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182275 | 2025-002 | Material Weakness | Yes | N |
| 393679 | 2025 | 2026-03-24 | 1182274 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182273 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182272 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182271 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182270 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182269 | 2025-001 | Material Weakness | Yes | P |
| 393679 | 2025 | 2026-03-24 | 1182268 | 2025-001 | Material Weakness | Yes | P |
| 344457 | 2024 | 2025-03-03 | 1101690 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101689 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101688 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101687 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101686 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101685 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101684 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101683 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101682 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101681 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101680 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 1101679 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525248 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525247 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525246 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525245 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525244 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525243 | 2024-002 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525242 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525241 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525240 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525239 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525238 | 2024-001 | Significant Deficiency | - | N |
| 344457 | 2024 | 2025-03-03 | 525237 | 2024-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960656 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960655 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960654 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960653 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960652 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960651 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960650 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960649 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960648 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960647 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960646 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 960645 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384214 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384213 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384212 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384211 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384210 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384209 | 2023-002 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384208 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384207 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384206 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384205 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384204 | 2023-001 | Significant Deficiency | - | N |
| 297294 | 2023 | 2024-03-25 | 384203 | 2023-001 | Significant Deficiency | - | N |